Manufacturer record

Shivani Pharmaceuticals: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Shivani Pharmaceuticals (Himachal Pradesh) were declared Not of Standard Quality between August 2025 and November 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: SPT-9584A, Paracetamol Tablets IP (exp Oct 2026). RDTL, Bellary, Karnataka (state lab) found it not of standard quality: Test for Dissolution. Listed in the November 2025 alert.

Records by type

2 records linked to Shivani Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Aug 2025 to Nov 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2025
2
Products affected
Assay
Most common failure
Nov 2025
Latest alert

Flagged batches per year

2025 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Paracetamol Tablets IP Batch SPT-9584AMfg Nov 2024 · Exp Oct 2026 Test for DissolutionDissolution RDTL, Bellary, KarnatakaState lab Nov 2025
Ferrous Ascorbate & Folic Acid Suspension IP Batch SPL-9104Mfg May 2024 · Exp Oct 2025 Assay of Folic AcidAssay Drug Testing Laboratory Baddi, Distt. Solan (H.P.)173205State lab Aug 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.